We are live on ! Find out more
AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of AVEO yet.

AVEO Hedge Fund Activity: Q1 2023 in Review

0 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q1 2023, worth a combined $0 — down 100% from $368M a quarter earlier.

Sellers outnumbered buyers: 110 funds closed out of AVEO and 0 opened new positions — a net loss of 110 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $22.6M sold.

  • 0 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q1 2023, down from 110 in Q4 2022.
  • Funds reported $0 of AVEO Pharmaceuticals, Inc. stock for Q1 2023, down 100% quarter-over-quarter.
  • 0 funds opened new AVEO Pharmaceuticals, Inc. positions in Q1 2023 and 110 closed out, a net change of -110 holders.
  • The largest AVEO Pharmaceuticals, Inc. seller in Q1 2023 was Vanguard Group, an estimated $22.6M sold.

Based on aggregated 13F filings for Q1 2023.